Conducting the largest and most complex trials in the industry
Scottsdale, AZ and Waltham, MA
Joined May 2020
- Tweets283
- Following71
- Followers51
- Likes0
Welcome Charles Gatt, Executive Director, Medical Application Services! Charles brings clinical trial imaging and AI experience to IE’s Medical and Scientific Affairs team.
#ImagingEndpoints #ClinicalTrials
Please join us in welcoming Dr. Souhil Zaim as Chief Scientific Officer at Imaging Endpoints.
With 25+ years of experience in medical imaging, clinical research, and scientific leadership, Dr. Zaim will help advance our mission to Connect Imaging to the Cure.
#ImagingEndpoints
Join Dr. Ron Korn, Founder & Chief Medical Officer of Imaging Endpoints, at ESMO Congress 2026 to explore how scientifically rigorous, imaging-driven strategies can support confident decision-making throughout your oncology trial.
hubs.li/Q04zzQhq0
If you’re attending EANM 2026 in Vienna, Austria, make sure to connect with our Founder & Chief Medical Officer, Dr. Ron Korn, MD, PhD.
Scan the QR code below or click the link below to reserve a spot!
hubs.li/Q04zrd730
Join us at Booth #19023 to meet our medical, scientific, and operational experts and discuss how Imaging Endpoints can help optimize your clinical development programs.
hubs.li/Q04hS-610
📅 ASCO Annual Meeting 2026
📍 Chicago, IL
🗓️ May 30 – June 1
📌 Booth #19023
Imaging Endpoints’ Founder and Chief Medical Officer, Ron Korn, will be participating in the RAISE* Community Meeting panel:
“Radiopharmaceutical Therapy in Oncology: Practical Integration for Practicing Oncologists.”
We’re ready for SNMMI 2026!
Meet the Imaging Endpoints team at Booth #522.
📅 May 30 – June 2
📍 Los Angeles Convention Center, Los Angeles, CA
👉 Schedule your meeting now: hubs.li/Q04gBXGy0 or "Scan the QR code"
Advances in imaging, especially radiomics and the emergence of AI and machine learning for downstream analysis, are transforming lung cancer detection and management in clinical trials.
Full Article: hubs.li/Q04gcGPP0
We’re ready for ASCO 2026!
Meet the Imaging Endpoints team at Booth #19023 to explore how we’re advancing oncology trials with customized imaging strategies, regulatory expertise, and cutting-edge technologies.
👉 Schedule your meeting now: https hubs.li/Q04fPZMR0
Integrating PSMA PET and Molecular Imaging into Response Assessment for Prostate Cancer Clinical Trials
Read the full story here.
hubs.li/Q04fqxX70
The Expanding Role of Imaging in Theranostic Trials for Hematologic Malignancies
Read the full post here: hubs.li/Q045KbL10
#Theranostics #ClinicalTrials #MolecularImaging #RadioligandTherapy #HematologicMalignancies #NuclearMedicine #PrecisionMedicine #ImagingEndpoints
Dr. Ron Korn, MD, PhD will be attending ASCO GU 2026 in San Francisco.
We welcome the opportunity to connect.
Schedule time with Dr. Korn here: hubs.li/Q044fb2d0
#ASCOGU #GUOncology #ClinicalTrials #Radiopharma #OncologyResearch
SCOPE brings together clinical operations leaders focused on improving trial execution and outcomes. If you are interested in discussing how IE optimized imaging approaches can help reduce operational risk and support trial success, let’s connect.
hubs.li/Q040WVQh0
Modern NET trials rely on quantitative SSTR PET, dosimetry, and harmonized central imaging. Integrating RECIST 1.1 with SSTR PET and lesion-level dosimetry supports better patient selection, precision PRRT, and submission-ready trial data.
Read More: hubs.ly/Q040vMs20
Excited to announce that Imaging Endpoints will be at the ASCO GI Cancers Symposium 2026 in San Francisco! 🌟
🗓️ When: January 08-09, 2026
📍 Where: Table #12
👉 Schedule a meeting with us today! hubs.li/Q03YXgH30
Together, let’s change the image of what’s possible.
HCC’s rising mortality makes precise imaging essential in trials. Integrating targeted PET tracers with LI-RADS and RECIST/mRECIST improves staging, treatment allocation, and early response assessment.
Read more: hubs.li/Q03WCyj70
#HCC #OncologyTrials #MedicalImaging
We’re thrilled to participate in this year’s ASH Annual Meeting from December 6th–8th at Booth #981!
Let’s connect and discuss how we can collaborate to revolutionize clinical trials with state-of-the-art solutions.
Click here to secure your spot: hubs.li/Q03Vg6240
CD8 PET Imaging: Advancing Immunotherapy and Trial Decisions
Imaging Endpoints is leading CD8 PET integration in trials, mapping immune deserts, informing therapy adjustments, and identifying patients most likely to benefit.
Read full article here at: hubs.li/Q03Q0scw0
We’re excited to connect with you at SITC 2025 in Maryland, USA (Nov 7–8)!
📍 Booth #339
📅 Schedule a meeting with Dr. Korn: hubs.li/Q03PWbfj0
Let’s explore how we can enhance your clinical trials together.
Have you ever wondered if there’s a more dynamic way to assess solid tumor treatment efficacy or predict when a tumor will double or shrink by half?
👉Discover how eTGK models transform tumor response evaluation hubs.li/Q03MWnCh0
#ClinicalTrials #Oncology #ImagingEndpoints
